These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29346317)

  • 1. Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.
    Mukherjee S; Baidoo JNE; Sampat S; Mancuso A; David L; Cohen LS; Zhou S; Banerjee P
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29346317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
    Mukherjee S; Hussaini R; White R; Atwi D; Fried A; Sampat S; Piao L; Pan Q; Banerjee P
    Cancer Immunol Immunother; 2018 May; 67(5):761-774. PubMed ID: 29453519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression.
    Mukherjee S; Debata PR; Hussaini R; Chatterjee K; Baidoo JNE; Sampat S; Szerszen A; Navarra JP; Fata J; Severinova E; Banerjee P; Castellanos MR
    Oncotarget; 2017 Sep; 8(37):60904-60916. PubMed ID: 28977833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.
    Mukherjee S; Baidoo J; Fried A; Atwi D; Dolai S; Boockvar J; Symons M; Ruggieri R; Raja K; Banerjee P
    Int J Cancer; 2016 Dec; 139(12):2838-2849. PubMed ID: 27543754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma.
    Piao L; Mukherjee S; Chang Q; Xie X; Li H; Castellanos MR; Banerjee P; Iqbal H; Ivancic R; Wang X; Teknos TN; Pan Q
    Oncotarget; 2017 Sep; 8(36):60025-60035. PubMed ID: 28947951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
    Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
    J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages.
    Zhu N; Chen S; Jin Y; Wang M; Fang L; Xue L; Hua D; Zhang Z; Jia M; Hao M; Zhang C
    ACS Nano; 2024 Apr; 18(17):11165-11182. PubMed ID: 38626338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Einbond LS; Zhou J; Wu HA; Mbazor E; Song G; Balick M; DeVoti JA; Redenti S; Castellanos MR
    Br J Cancer; 2021 Mar; 124(5):901-913. PubMed ID: 33257842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using curcumin to turn the innate immune system against cancer.
    Mukherjee S; Baidoo JNE; Fried A; Banerjee P
    Biochem Pharmacol; 2020 Jun; 176():113824. PubMed ID: 31987852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
    BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
    Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
    Front Immunol; 2021; 12():637053. PubMed ID: 34108959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Perspective on Cancer Therapy: Changing the Treaded Path?
    Baidoo JNE; Mukherjee S; Kashfi K; Banerjee P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
    Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
    PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
    Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
    Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.